31 March 2014 Notification of Major Interest in Shares
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: 		Futura Medical
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify): Increase in Total Voting Rights X
3. Full name of person(s) subject to the
notification obligation: 		Investec Wealth & Investment Limited
4. Full name of shareholder(s)
(if different from 3.): 		N/A
5. Date of the transaction and date on which the threshold is crossed orreached:

27th March 2014

6. Date on which issuer notified:

31st March 2014

7. Threshold(s) that is/are crossed or reached:

From 4% to 3%

8. Notified details:
A: Voting rights attached to shares
Class/type of
shares

if possible using
the ISIN CODE 		Situation previous
to the triggering
transaction 		Resulting situation after the triggering transaction
Number
of
Shares 		Number
of
Voting
Rights 		Number
of shares 		Number of voting
rights 		% of voting rights
Direct Indirect Direct Indirect Direct Indirect
Ordinary Shares

GB0033278473 		3,540,152 3,540,152 3,540,152 3.58%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Expiration date Exercise/ Conversion Period Number of voting rights that may be acquired if the instrument is exercised/ converted. % of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument Exercise price Expiration date Exercise/
Conversion period 		Number of voting rights instrument refers to % of voting rights
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
3,545,452 3.58%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Client holdings registered in the name of Nominee companies 100% owned by Investec Wealth & Investment Limited.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold: N/A
12. Date on which proxy holder will cease to hold voting rights: N/A
13. Additional information: N/A
14. Contact name: Phil Beardwell Chartered FCSI
Senior Compliance Manager
15. Contact telephone number: 020 7597 1356

For further information please contact:

Futura Medical plc
James Barder, Chief Executive
+44 (0) 1483 685 670
james.barder@futuramedical.com
www.futuramedical.com

Nominated Adviser:
N+1 Singer
Aubrey Powell / Joe Stroud
Tel: +44 (0) 20 7496 3000

distributed by